News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Graf Susan E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Graf Susan E (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Bought 5,010 shares
@ $0.27, valued at
$1.4k
Granted 10,000 options to buy
@ $0.285, valued at
$2.9k
|
|
| 06/15/2022 |
4
| Graf Susan E (Director) has filed a Form 4 on Finch Therapeutics Group, Inc.|
Txns:
| Granted 44,843 options to buy
@ $2.79, valued at
$125.1k
|
|
| 04/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/13/2018 |
4
| Graf Susan E (Chief Business Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 106,344 options to buy
@ $16, valued at
$1.7M
|
|
| 02/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/26/2016 |
4
| Graf Susan E (Chief Business Officer) has filed a Form 4 on Epizyme, Inc.|
Txns:
| Granted 178,642 options to buy
@ $12.12, valued at
$2.2M
|
|
| 04/26/2016 |
3
| Graf Susan E (Chief Business Officer) has filed a Form 3 on Epizyme, Inc. |
| 02/24/2015 |
4
| Graf Susan E (VP,Corp Development & Strategy) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Unknown transaction of 4,761 shares
@ $46, valued at
$219k
Disposed/sold 41,289 options to buy
@ $14.9, valued at
$615.2k
Disposed/sold 11,874 options to buy
@ $38.27, valued at
$454.4k
Disposed/sold 10,905 restricted stock units
@ $0
Disposed/sold 2,893 restricted stock units
@ $0
Disposed/sold 11,577 restricted stock units
@ $0 |
|
| 02/20/2015 |
4
| Graf Susan E (VP,Corp Development & Strategy) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 484 shares
@ $45.85, valued at
$22.2k
Exercised 1,445 restricted stock units
@ $0
Granted 10,905 restricted stock units
@ $0 |
|
| 02/11/2015 |
4
| Graf Susan E (VP, Corp Development & Strateg) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Sold 6,711 shares
@ $45.8701, valued at
$307.8k
Exercised 6,711 options to buy
@ $14.9, valued at
$100k
|
|
| 06/19/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/14/2014 |
4
| Graf Susan E (VP Corp Development & Strategy) has filed a Form 4 on NPS PHARMACEUTICALS INC|
Txns:
| Granted 11,874 options to buy
@ $38.27, valued at
$454.4k
Granted 4,338 restricted stock units
@ $0 |
|
| 06/18/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|